Benefits of Mammography Outweigh Harms In Women with Increased Risk, Starting at Age 40
ASCO Publishes Guidelines For Dosing Chemotherapy Correctly in Obese Patients
Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival
Researchers Link Cancer Risk And DMPA Birth Control Use
Breast-Conserving Procedures Lead To Frequent Follow-up Care
False-Positive Mammograms Can Indicate Higher Cancer Risk
Proposed Surveillance Model Aims To Reduce Post-Treatment Pain
Adding Avastin Did Not Improve Standard Chemotherapy Regimen
Ibrutinib Demonstrates Responses In Large B-Cell Lymphomas
Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial
Perifosine Fails Primary Endpoint, Zentaris CEO Explores Options
Translplants Not Best Choice in Subset of ALL Patients
PET Response Can Predict Increased Survival In Patients
Cancer Incidence Rates Climb In HIV-Positive Female Populations
Technology Isolates and Recovers Circulating Liver Tumor Cells
Survey Shows That One-Third Of Patients Are Undertreated
Trials Approved by NCI CTEP For the Month of April
FDA Approves Votrient For Soft Tissue Sarcomas
Trending Stories
- Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group - Gardiner Harris, acclaimed health care and pharma journalist, on his New York Times bestselling book
- ACOG says it will no longer accept federal funding
- Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- The Med Student’s Memo – Research Concerns
- FY25 paylines drop to 4th percentile—a historic low—as NCI braces for Trump’s FY26 budget cuts
